AuntMinnie
OCTOBER 9, 2023
Alzheimer’s disease patients with cognitive impairment or dementia who were referred for amyloid PET scans had fewer hospitalizations compared with a matched control group, according to a study published October 9 in JAMA Neurology. Each participant was matched to a control Medicare beneficiary who had not undergone amyloid PET.
AuntMinnie
JANUARY 30, 2024
F-18 FDG-PET is an established approach for diagnosing inflammation based on its ability to visualize increased cellular glucose metabolism, and the researchers hypothesized that it could be useful in patients with neurosarcoidosis. In all three cases, gadolinium-enhanced MRI scans did not show abnormalities.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
NOVEMBER 25, 2024
F-18 florbetaben PET scans for diagnosing Alzheimer’s disease can be reduced from 20 minutes to five minutes without losing accuracy, according to a recent study. Our findings suggest that shorter scan times are a viable and effective option for brain amyloid PET imaging in clinical settings,” the group wrote.
AuntMinnie
NOVEMBER 9, 2023
National Institutes of Health (NIH) has highlighted a study that shows cardiac PET scans can help identify people at risk for Parkinson’s disease and Lewy body dementia. Heart and brain PET scans from a study participant who developed Parkinson’s disease support a “body first” progression.
AuntMinnie
FEBRUARY 12, 2024
Chinese clinicians have provided evidence in a “real-world study” that shows amyloid PET imaging is effective for diagnosing and managing patients with Alzheimer’s disease, according to a study published February 8 in Alzheimer’s and Dementia. of patients, noted lead author Ke-Liang Chen, MD, a neurologist at Fudan University. “In
AuntMinnie
JANUARY 23, 2025
The accumulation of brain amyloid deposits is a mechanism underlying Alzheimers disease, with amyloid PET scans used to diagnose the disease. To address the knowledge gap, the group identified 182 out of 1,680 participants in an Alzheimers disease study in France and Monaco who had both PET scans and HSV-1 blood tests available.
AuntMinnie
OCTOBER 27, 2023
Patients with less tau pathology on PET scans may respond better to treatment with the new Alzheimer’s disease drug donanemab, according to an October 25 news report in the journal Practical Neurology. Research suggests that the accumulation of these proteins is a continuous process that starts decades before the onset of symptoms.
Expert insights. Personalized for you.
277 
Let's personalize your content